Developer docs
API playgroundTry for free, no card

Search company profiles

Synple Chem

Full company profile

uuid0006f7d

Namestring
Synple Chem
Legal namestring
Synple Chem AG
Websiteurl
synplechem.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Synple Chem AG is a Switzerland-based (Kemptthal/Zurich) private company founded in 2016 as a spin-off from ETH Zürich, specializing in capsule-based automated chemical synthesis for drug discovery. Its core technology packages reagents, solvents, and purification materials into single-use, scannable, chip-enabled reagent cartridges covering eight reaction classes with more than 40 reagents, loaded into compact automated synthesizers (Synple 1, Synple 2, and the parallel Synple Unity) that perform reaction, work-up, and purification inside an enclosed reactor. The system is positioned as analogous to a capsule coffee machine: a user loads starting material and a cartridge, and a purified compound is produced in 5-10 minutes with claims of 70% lower cost per molecule and 90% less waste versus manual synthesis. In 2023, the company extended the platform with Synple 4.0 Discovery Platform, which uses machine learning to enumerate tractable virtual libraries of more than 7 x 10^12 compounds and bridges virtual screening hits with physical synthesis via integrations with Biosolveit, Hyperlab, CHEESE, Pharmacelera, Schrödinger, Fujitsu, OpenEye, and Alipheron.

The company sells automated synthesizers under a quote-based enterprise model across Europe, the UK, and the US, with a distributor channel being developed in Asia, and earns recurring revenue from single-use reagent cartridges (delivered within one week). Customers include pharmaceutical companies such as Sanofi and AstraZeneca and contract research organizations such as BioBlocks, with use cases spanning PROTAC synthesis, N-heterocycle formation, reductive amination, and SnAP chemistry. Synple Chem was acquired by eMolecules Inc., a San Diego-based chemical search engine provider, in September 2024, combining its virtual compound library and automation with eMolecules' screening platform. The company operates with 1-10 employees, has minimal disclosed external funding (a 2016 Venture Kick tranche of $9,894), and does not publicly disclose revenue.

Short descriptiontext

Synple Chem AG builds capsule-based automated chemical synthesizers and consumable reagent cartridges that let pharma and CRO drug discovery teams run reaction, work-up, and purification in a single enclosed instrument without manual synthesis expertise.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKemptthal, Switzerland
HQ citystring
Kemptthal
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated chemical synthesis, reagent cartridges, drug discovery instruments, capsule-based synthesis, laboratory automation equipment
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Medicinal Chemicals & Botanical Products2833
Product category
Laboratory Automation Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Automated synthesis instruments
TypeHardware Sales
Description

Sale of Synple 1, Synple 2, and Synple Unity automated synthesis instruments to pharmaceutical companies, CROs, and research institutions. Lead time of four weeks for machine delivery.

synplechem.com
2Reagent cartridges and consumables
TypeUsage Based
Description

Recurring revenue from single-use disposable reagent capsules (cartridges) covering eight reaction classes with more than 40 reagents. Cartridges are delivered within one week and are essential for each synthesis run.

synplechem.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Pricing details1 tier
1Automated synthesizer (Synple 1, Synple 2, Synple Unity)
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Machine purchase pricing is quote-based. Lead time of four weeks.

synplechem.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Synple 1
Description

First generation automated synthesis device installed with customers since May 2018.

synplechem.com
+3 more records
Core offering1 text field

Synple Chem develops and sells capsule-based automated chemical synthesizers (Synple 1, Synple 2, Synple Unity) together with single-use, disposable reagent cartridges covering eight reaction classes. The hardware, software, and pre-optimized chemistry are bundled into one device that performs reaction, work-up, and purification autonomously, analogous to a capsule coffee maker, allowing drug discovery chemists to generate research compounds in 5–10 minutes without manual synthesis expertise.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5x more efficient — 5-10 minutes per reaction vs. several hours manually
+4 more records
Product overview1 text field

Synple Chem offers a suite of automated chemical synthesis products centered around capsule-based technology. The core product line includes Synple 1 (first generation, deployed 2018), Synple 2 (capsule-based synthesizer launched October 2019), and Synple Unity (parallel synthesizer). Synple 4.0 Discovery Platform bridges virtual compound libraries with automated synthesis, enabling hit validation from vast virtual libraries. The 3-in-1 solution combines hardware (automated synthesizers), software (reaction control and optimization), and optimized chemical processes (via reagent cartridges). Consumables include single-use reagent cartridges covering eight reaction classes with 40+ reagents, and Synple Reaction Kits for specific applications.

Product and service3 records
1Synple 2
CategoryAutomated chemical synthesizer
Description

Compact capsule-based automated chemical synthesizer that performs reaction, work-up, and purification autonomously in 5–10 minutes per run for pharmaceutical and biotech drug discovery customers. Features a 25 x 35 cm footprint, fully enclosed reactor for safety, automated cleaning, and modifiable time and temperature parameters.

2Synple 1
CategoryAutomated chemical synthesizer
Description

First-generation automated chemical synthesis device from Synple Chem, deployed with customers since May 2018. Runs single reactions using the capsule-based reagent cartridge approach.

3Synple Unity
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-25
Description

In September 2024, Synple Chem was acquired by eMolecules Inc., a San Diego-based chemical search engine provider. The acquisition combines Synple's virtual compound library and automation solutions with eMolecules' platform, significantly expanding the available chemical space and research capabilities. As of the acquisition date, Synple Chem became part of the eMolecules group.

2Millipore-Sigma / Sigma-Aldrich
Strategic tierCoreTypeGTM or Marketing Partner
Description

Millipore-Sigma (Sigma-Aldrich) partnered with Synple Chem on a joint webinar (November 2023) presenting an overview of the SYNTHIA and Synple platforms and results of their collaboration on accelerating synthesis from synthesis path design to obtaining the molecule. This represents a significant go-to-market collaboration with a major life sciences supplier.

synplechem.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Chemistry World (a publication of the Royal Society of Chemistry) hosted a joint webinar with Synple Chem in October 2021 on automated capsule chemistry. This represents a media partnership for reach into the chemistry community.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Synple Chem originated as a spin-off from ETH Zürich. The company was founded on technology and research developed by Prof. Jeffrey Bode's group at ETH. Prof. Bode has been involved in multiple Synple Chem webinars and publications, including SnAP reagent chemistry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based specialist in flow chemistry and automated synthesis platforms for drug discovery and process chemistry. Direct competitor in lab automation hardware for medicinal chemistry applications.

TypeDirect peer
Description

US-based life sciences tools company offering automated reaction screening and synthesis platforms (e.g., Freeslate-style automation) to pharma and biotech drug discovery. Direct competitor in workflow automation consumables.

TypeBroad incumbent
Description

Sweden-listed provider of lab instruments and consumables for medicinal chemistry, sample preparation, and purification (flash chromatography, peptide synthesis). Sells both hardware and consumables to the same pharma medicinal chemistry buyer.

TypeBroad incumbent
Description

Parent company of Synple Chem since September 2024; a San Diego-based chemical search engine and compound sourcing marketplace serving pharma R&D. Directly comparable buyer base and complementary offering (virtual library + now physical synthesis).

TypeEmerging player
Description

Chemical sourcing marketplace and compound supplier serving pharma R&D. Adjacent to Synple's positioning as a compound access + synthesis platform; comparable buyer relationships.

TypeDirect peer
Description

UK-based manufacturer of automated lab reactors and parallel synthesis tools for chemistry, pharma, and biotech R&D. Competes in the same automated synthesis hardware category as Synple's Synple 1/2/Unity line.

TypeRegional player
Description

UK-based supplier of laboratory tools and synthesis automation products (e.g., DrySyn, ReactoMate) for chemistry labs. Smaller, more UK-focused peer in the synthesis lab tools category.

TypeEmerging player
Description

Ukraine-based provider of building blocks, screening compounds, and custom synthesis services for drug discovery, with a focus on large virtual chemical libraries. Complementary to Synple's library-and-synthesis thesis and competing with Synple 4.0.

TypeDirect peer
Description

Swiss-based provider of automated synthesis and workflow platforms for pharma, biotech, and materials science. Competes head-to-head in automated chemical synthesis instrumentation with broader reaction-class coverage than Synple.

TypeDirect peer
Description

UK-based manufacturer of automated flow chemistry and batch synthesis reactors (e.g., Asia, Atlas) for pharma R&D. Comparable automated synthesis instrument vendor serving the same medicinal chemistry customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synple Chem

Laboratory Automation Equipmentsynplechem.com

Synple Chem AG builds capsule-based automated chemical synthesizers and consumable reagent cartridges that let pharma and CRO drug discovery teams run reaction, work-up, and purification in a single enclosed instrument without manual synthesis expertise.

What Synple Chem does

Synple Chem AG is a Switzerland-based (Kemptthal/Zurich) private company founded in 2016 as a spin-off from ETH Zürich, specializing in capsule-based automated chemical synthesis for drug discovery. Its core technology packages reagents, solvents, and purification materials into single-use, scannable, chip-enabled reagent cartridges covering eight reaction classes with more than 40 reagents, loaded into compact automated synthesizers (Synple 1, Synple 2, and the parallel Synple Unity) that perform reaction, work-up, and purification inside an enclosed reactor. The system is positioned as analogous to a capsule coffee machine: a user loads starting material and a cartridge, and a purified compound is produced in 5-10 minutes with claims of 70% lower cost per molecule and 90% less waste versus manual synthesis. In 2023, the company extended the platform with Synple 4.0 Discovery Platform, which uses machine learning to enumerate tractable virtual libraries of more than 7 x 10^12 compounds and bridges virtual screening hits with physical synthesis via integrations with Biosolveit, Hyperlab, CHEESE, Pharmacelera, Schrödinger, Fujitsu, OpenEye, and Alipheron.

The company sells automated synthesizers under a quote-based enterprise model across Europe, the UK, and the US, with a distributor channel being developed in Asia, and earns recurring revenue from single-use reagent cartridges (delivered within one week). Customers include pharmaceutical companies such as Sanofi and AstraZeneca and contract research organizations such as BioBlocks, with use cases spanning PROTAC synthesis, N-heterocycle formation, reductive amination, and SnAP chemistry. Synple Chem was acquired by eMolecules Inc., a San Diego-based chemical search engine provider, in September 2024, combining its virtual compound library and automation with eMolecules' screening platform. The company operates with 1-10 employees, has minimal disclosed external funding (a 2016 Venture Kick tranche of $9,894), and does not publicly disclose revenue.

Synple Chem firmographics

Firmographics
Name
Synple Chem
Legal name
Synple Chem AG
Website
https://synplechem.com
Company type
Private
Founded year
2016
Operating status
Acquired
Headcount range
1–10 employees
Short description
Synple Chem AG builds capsule-based automated chemical synthesizers and consumable reagent cartridges that let pharma and CRO drug discovery teams run reaction, work-up, and purification in a single enclosed instrument without manual synthesis expertise.
Ownership category
akta.pro rank

Synple Chem industry classification

Industry
Product category
Laboratory Automation Equipment
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medicinal and Botanical Manufacturing (325411)
SIC
Surgical & Medical Instruments & Apparatus (3841), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Automated chemical synthesis
  • Reagent cartridges
  • Drug discovery instruments
  • Capsule-based synthesis
  • Laboratory automation equipment

Where Synple Chem is headquartered

Location

Headquarters

HQ city
Kemptthal
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Synple Chem business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. Automated synthesis instruments: Sale of Synple 1, Synple 2, and Synple Unity automated synthesis instruments to pharmaceutical companies, CROs, and research institutions. Lead time of four weeks for machine delivery.
  2. Reagent cartridges and consumables: Recurring revenue from single-use disposable reagent capsules (cartridges) covering eight reaction classes with more than 40 reagents. Cartridges are delivered within one week and are essential for each synthesis run.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractAutomated synthesizer (Synple 1, Synple 2, Synple Unity)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Synple Chem product offering

Product offering

Core offering

Synple Chem develops and sells capsule-based automated chemical synthesizers (Synple 1, Synple 2, Synple Unity) together with single-use, disposable reagent cartridges covering eight reaction classes. The hardware, software, and pre-optimized chemistry are bundled into one device that performs reaction, work-up, and purification autonomously, analogous to a capsule coffee maker, allowing drug discovery chemists to generate research compounds in 5–10 minutes without manual synthesis expertise.

Product overview

Synple Chem offers a suite of automated chemical synthesis products centered around capsule-based technology. The core product line includes Synple 1 (first generation, deployed 2018), Synple 2 (capsule-based synthesizer launched October 2019), and Synple Unity (parallel synthesizer). Synple 4.0 Discovery Platform bridges virtual compound libraries with automated synthesis, enabling hit validation from vast virtual libraries. The 3-in-1 solution combines hardware (automated synthesizers), software (reaction control and optimization), and optimized chemical processes (via reagent cartridges). Consumables include single-use reagent cartridges covering eight reaction classes with 40+ reagents, and Synple Reaction Kits for specific applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Synple 1: First generation automated synthesis device installed with customers since May 2018.
  • Synple 2
  • Synple 4.0
  • Synple Unity

Products and services

  • Synple 2 Compact capsule-based automated chemical synthesizer that performs reaction, work-up, and purification autonomously in 5–10 minutes per run for pharmaceutical and biotech drug discovery customers. Features a 25 x 35 cm footprint, fully enclosed reactor for safety, automated cleaning, and modifiable time and temperature parameters.
  • Synple 1 First-generation automated chemical synthesis device from Synple Chem, deployed with customers since May 2018. Runs single reactions using the capsule-based reagent cartridge approach.
  • Synple Unity

Quantifiable outcome

  • 5x more efficient — 5-10 minutes per reaction vs. several hours manually
  • +4 more outcomes

Companies that use Synple Chem

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Synple Chem technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature4 records

Synple Chem partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • eMolecules Inc.coreStrategic or Co-development Partner · 25 September 2024In September 2024, Synple Chem was acquired by eMolecules Inc., a San Diego-based chemical search engine provider. The acquisition combines Synple's virtual compound library and automation solutions with eMolecules' platform, significantly expanding the available chemical space and research capabilities. As of the acquisition date, Synple Chem became part of the eMolecules group.
  • Millipore-Sigma / Sigma-AldrichcoreGTM or Marketing PartnerMillipore-Sigma (Sigma-Aldrich) partnered with Synple Chem on a joint webinar (November 2023) presenting an overview of the SYNTHIA and Synple platforms and results of their collaboration on accelerating synthesis from synthesis path design to obtaining the molecule. This represents a significant go-to-market collaboration with a major life sciences supplier.
  • Chemistry WorldminorGTM or Marketing PartnerChemistry World (a publication of the Royal Society of Chemistry) hosted a joint webinar with Synple Chem in October 2021 on automated capsule chemistry. This represents a media partnership for reach into the chemistry community.
  • ETH Zürich (Prof. Jeffrey Bode group)coreStrategic or Co-development PartnerSynple Chem originated as a spin-off from ETH Zürich. The company was founded on technology and research developed by Prof. Jeffrey Bode's group at ETH. Prof. Bode has been involved in multiple Synple Chem webinars and publications, including SnAP reagent chemistry.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Synple Chem competitors and assessment

Company assessment

Direct peers

  • AM Technology: UK-based specialist in flow chemistry and automated synthesis platforms for drug discovery and process chemistry. Direct competitor in lab automation hardware for medicinal chemistry applications.
  • Unchained Labs: US-based life sciences tools company offering automated reaction screening and synthesis platforms (e.g., Freeslate-style automation) to pharma and biotech drug discovery. Direct competitor in workflow automation consumables.
  • H.E.L Group: UK-based manufacturer of automated lab reactors and parallel synthesis tools for chemistry, pharma, and biotech R&D. Competes in the same automated synthesis hardware category as Synple's Synple 1/2/Unity line.
  • Chemspeed Technologies: Swiss-based provider of automated synthesis and workflow platforms for pharma, biotech, and materials science. Competes head-to-head in automated chemical synthesis instrumentation with broader reaction-class coverage than Synple.
  • Syrris: UK-based manufacturer of automated flow chemistry and batch synthesis reactors (e.g., Asia, Atlas) for pharma R&D. Comparable automated synthesis instrument vendor serving the same medicinal chemistry customer base.

Broad incumbents

  • Biotage: Sweden-listed provider of lab instruments and consumables for medicinal chemistry, sample preparation, and purification (flash chromatography, peptide synthesis). Sells both hardware and consumables to the same pharma medicinal chemistry buyer.
  • eMolecules: Parent company of Synple Chem since September 2024; a San Diego-based chemical search engine and compound sourcing marketplace serving pharma R&D. Directly comparable buyer base and complementary offering (virtual library + now physical synthesis).

Emerging players

  • MolPort: Chemical sourcing marketplace and compound supplier serving pharma R&D. Adjacent to Synple's positioning as a compound access + synthesis platform; comparable buyer relationships.
  • Enamine: Ukraine-based provider of building blocks, screening compounds, and custom synthesis services for drug discovery, with a focus on large virtual chemical libraries. Complementary to Synple's library-and-synthesis thesis and competing with Synple 4.0.

Regional players

  • Asynt: UK-based supplier of laboratory tools and synthesis automation products (e.g., DrySyn, ReactoMate) for chemistry labs. Smaller, more UK-focused peer in the synthesis lab tools category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Synple Chem social profiles

Digital presence

Synple Chem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synple Chem leadership team

Management profile

Number of profiles

Profiles1 record

Synple Chem funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synple Chem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synple Chem

What does Synple Chem do?

Synple Chem develops and sells capsule-based automated chemical synthesizers (Synple 1, Synple 2, Synple Unity) together with single-use, disposable reagent cartridges covering eight reaction classes. The hardware, software, and pre-optimized chemistry are bundled into one device that performs reaction, work-up, and purification autonomously, analogous to a capsule coffee maker, allowing drug discovery chemists to generate research compounds in 5–10 minutes without manual synthesis expertise.

Is Synple Chem a public or private company?

Synple Chem is a private company. It is classified as corporate owned and is currently acquired.

When was Synple Chem founded?

Synple Chem was founded in 2016. It employs 1 to 10 people.

Where is Synple Chem based?

Synple Chem is headquartered in Kemptthal, Switzerland, in the Europe region.

How does Synple Chem make money?

Two revenue lines are on record. Automated synthesis instruments are the primary driver. The others are reagent cartridges and consumables.

Who are Synple Chem's main competitors?

Direct peers on record are AM Technology, Unchained Labs, H.E.L Group, Chemspeed Technologies and Syrris. Broad incumbents are Biotage and eMolecules. Emerging players are MolPort and Enamine. Asynt is listed as a regional player.

Does Synple Chem have an API?

No public API is recorded for Synple Chem.

What industry is Synple Chem in?

Synple Chem's product category is Laboratory Automation Equipment. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals